News and Press Releases
MedExecWomen Hosts 6th Annual Conference to Discuss Future of Medtech Industry
18 March 2025 -- Massachusetts, US -- MedExecWomen, a non-profit organization focused on empowering executive women in medtech to accelerate the positive impact of medical devices, diagnostics, drug delivery, and...
Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: March 18, 2025
Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market
11 March 2025 -- Neumünster, Germany -- Tilray Medical, a division of Tilray Brands, Inc and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare...
Category: Other, Pharmaceutical
Posted: March 11, 2025
Cherwell supports microbiological environmental monitoring best practices conference
Cleanroom microbiology experts on hand at Pharmig’s specialist conference to discuss assessment of sterility in pharmaceutical manufacturing facilities 6 March 2025 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert,...
Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: March 6, 2025
Launton Business Centre Murdock Rd, Bicester OX26 4XB
ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025
24 January 2025 -- Cambridge, UK -- The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research...
Category: Drug Discovery, Other, Pharmaceutical
Posted: January 24, 2025
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
From Discovery Park to Merck, Top Industry Players to Showcase at London Biotechnology Show 2025
7 November 2024 -- London, UK -- Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 7, 2024
PTC Therapeutics to Participate at Upcoming Investor Conferences
4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov....
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 4, 2024
PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449
Travere Therapeutics to Present at Upcoming Investor Conferences
4 November 2024 -- California, US -- Travere Therapeutics, Inc today announced that company management will present in the following upcoming investor conferences in November: Guggenheim Securities Healthcare Innovation ConferenceMonday, November 11,...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 4, 2024
atai Life Sciences Announces Update on Beckley Psytech’s phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from phase 1 and First Patients Dosed in phase 2a
ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in a more consistent, controllable and shorter treatment paradigm of approximately two hours The...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 21, 2024
Numinus Wellness Announces Strategic Acquisition of MedBright AI
Plans name change to "Numinus Intelligence" leveraging its current revenue-generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright's AI-enabled clinical solution capabilities with Numinus'...
Category: Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2024
First participant dosed in research study investigating the effects of BPL-003, a novel formulation of 5-MeO-DMT, on the human brain
The study is the first of its kind to assess the effects of 5-MeO-DMT in the human brain and will investigate the neurophysiological effects of BPL-003, Beckley Psytech’s novel synthetic...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 3, 2024
Lykos Therapeutics Appoints Finance Veteran Scott Giacobello to the Board of Directors
30 May 2024 -- California, US -- Lykos Therapeutics, a company dedicated to transforming mental healthcare, announced the appointment of finance veteran Scott Giacobello to the company's Board of Directors, effective immediately. A...
Category: Biotechnology, Clinical Trials, Other
Posted: May 30, 2024
Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied
10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...
Category: Biotechnology
Posted: May 10, 2024
